Rinovagos en es it fr

Rinovagos Brand names, Rinovagos Analogs

Rinovagos Brand Names Mixture

  • Combivent Inhalation Aerosol (Ipratropium Bromide + Salbutamol Sulfate)
  • Combivent Inhalation Solution (Ipratropium Bromide + Salbutamol Sulfate)
  • Duovent Udv (Fenoterol Hydrobromide + Ipratropium Bromide)
  • Ratio-Ipra Sal Udv (Ipratropium Bromide + Salbutamol Sulfate)

Rinovagos Chemical_Formula


Rinovagos RX_link


Rinovagos fda sheet

Rinovagos FDA

Rinovagos msds (material safety sheet)

Rinovagos Synthesis Reference

K. Zeile et al.,U.S. Pat. 3,505,337 (1970)

Rinovagos Molecular Weight

332.457 g/mol

Rinovagos Melting Point


Rinovagos H2O Solubility

Freely soluble

Rinovagos State


Rinovagos LogP

No information avaliable

Rinovagos Dosage Forms

Aerosol (with propellants); Liquid; Metered-dose (aerosol); Metered-dose (pump); Solution

Rinovagos Indication

For maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.

Rinovagos Pharmacology

Ipratropium bromide, a synthetic ammonium compound structurally similar to atropine, is used as a bronchodilator in the management of cholinergic-mediated bronchospasm associated with chronic obstructive pulmonary disease and in the treatment of rhinorrhea associated with the common cold or with allergic or nonallergic seasonal rhinitis.

Rinovagos Absorption

Inhalation (local)-minimal; Nasal-rapid and minimal

Rinovagos side effects and Toxicity

LD50=1001mg/kg (orally in mice)

Rinovagos Patient Information

Rinovagos Organisms Affected

Humans and other mammals